(Q44795837)

6 December 2017

0 references

Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: are they really "off the hook"? (English)

1 reference

6 December 2017

1 reference

1 reference

McMahon BJ

1

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 December 2017

1 reference

6 December 2017

volume

28

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

265-267

1 reference

Hepatitis B virus infection

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

The clinical significance of molecular variation within the hepatitis B virus genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Workshop on Screening for Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

The natural history of asymptomatic hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280135

7 January 2021

Identifiers

DOI

10.1002/HEP.510280135

1 reference

6 December 2017

1 reference